Bold Therapeutics Inc.
Shane Harrypersad, PhD, currently works as a Senior Scientist in the CMC department at Bold Therapeutics Inc. Shane has previous experience as a Graduate Research Assistant at Simon Fraser University.
Bold Therapeutics Inc.
Bold Therapeutics is a clinical stage biotechnology company developing a first-in-class cancer therapy for the treatment of gastric, pancreatic, colorectal and other cancers in combination with existing anti-cancer therapies.